FGF23 and cardiac hypertrophy: In CKD, sKL can protect the myocardium from pathological stimuli, such as uremic toxins or FGF23 (26), even though myocardial hypertrophy still occurs in low sKL CKD mice in which phosphorus and FGF23 levels are controlled.